MEGHAN RICHARDS: Open Payments
NPI 1376257808 · HICKORY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,317 in 178 payments from 16 companies in 2025. Trend: 2023 $302 · 2024 $185 · 2025 $3,317
Food & beverage: $3,217Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 62 | $629 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $532 |
| Vanda Pharmaceuticals Inc. | 18 | $437 |
| Otsuka America Pharmaceutical, Inc. | 15 | $350 |
| Alkermes, Inc. | 13 | $250 |
| Neurocrine BioSciences, Inc. | 10 | $235 |
| E.R. Squibb & Sons, L.L.C. | 10 | $182 |
| Teva Pharmaceuticals USA, Inc. | 7 | $159 |
| Supernus Pharmaceuticals, Inc. | 5 | $138 |
| Axsome Therapeutics, Inc. | 1 | $124 |
Products named: VRAYLAR, CAPLYTA, FANAPT, REXULTI, INGREZZA, COBENFY, Qelbree, LYBALVI.
Industry payments across NC — which companies pay providers there.
